DnB Asset Management AS - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
DnB Asset Management AS ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$1,465,752,000
-51.4%
145,846
-40.1%
0.01%
-44.4%
Q1 2022$3,013,701,000
-43.7%
243,433
+4.1%
0.02%
-41.9%
Q4 2021$5,349,156,000
-44.9%
233,894
-46.7%
0.03%
-50.8%
Q3 2021$9,705,814,000
+20.0%
438,780
-29.7%
0.06%
+16.7%
Q2 2021$8,087,040,000
+50.1%
624,000
+50.4%
0.05%
+38.5%
Q1 2021$5,387,879,000
+291.3%
414,931
+316.8%
0.04%
+225.0%
Q4 2020$1,376,818,00099,5530.01%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders